Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy

Introduction: Atrial fibrillation (AF) and diabetes mellitus type 2 (DM2) often coexist; however, a small number of patients with DM2 undergoing catheter ablation (CA) of AF have been included in previous studies. The aim of this study was to evaluate safety and efficacy of ablation therapy in DM2 patients with drug refractory AF.

[1]  A. Dello Russo,et al.  Safety of Single Transseptal Puncture for Ablation of Atrial Fibrillation: Retrospective Study from a Large Cohort of Patients , 2007, Journal of cardiovascular electrophysiology.

[2]  R. Mantovan,et al.  Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. , 2007, Heart rhythm.

[3]  G. Hindricks,et al.  Venice Chart International Consensus Document on Atrial Fibrillation Ablation , 2007, Journal of cardiovascular electrophysiology.

[4]  J. Kalifa,et al.  Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus—single center experience , 2007, Journal of Interventional Cardiac Electrophysiology.

[5]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[6]  J. Halperin,et al.  Guidelines for the Management of Patients With Atrial Fibrillation , 2006 .

[7]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[8]  Jeetesh V. Patel,et al.  Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement? , 2006, Journal of Human Hypertension.

[9]  M. Movahed,et al.  Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. , 2005, International journal of cardiology.

[10]  G. Lip,et al.  Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. , 2005, International journal of cardiology.

[11]  Jeetesh V. Patel,et al.  The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure , 2005, Journal of thrombosis and haemostasis : JTH.

[12]  T. Rundek,et al.  Stroke prevention in diabetic and other high cardiovascular risk patients , 2005, Current diabetes reports.

[13]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[14]  J. Dimarco,et al.  Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. , 2005, American heart journal.

[15]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[16]  L. Råstam,et al.  Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community , 2004, Diabetes, obesity & metabolism.

[17]  T. Sugiyama,et al.  Diabetes influences the cardiac symptoms related to atrial fibrillation. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[18]  G. Mensah,et al.  Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.

[19]  I. Gelder,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2003 .

[20]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[21]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[22]  T. Potpara,et al.  The impact of diabetes mellitus on restoring and maintaining of sinus rhythm in patients with persistent atrial fibrillation , 2002 .

[23]  S. Lévy,et al.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.

[24]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[25]  H. Parving,et al.  Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy , 1995, BMJ.

[26]  G. Lip.  Does atrial fibrillation confer a hypercoagulable state? , 1995, The Lancet.

[27]  C. Sherbourne,et al.  The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups , 1994, Medical care.

[28]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[29]  T. Potpara,et al.  [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation]. , 2002, Srpski arhiv za celokupno lekarstvo.

[30]  Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society WRITING COMMITTEE MEMBERS , 2001 .

[31]  S. Amitani,et al.  Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.